Dr. Marie-Lyn Hecht is an associate partner in the Life Sciences Strategy practice of EY-Parthenon based in Zurich.
She has more than 10 years of experience in strategy consulting, and focuses on the pharmaceutical, biotech and medtech industries.
Marie-Lyn has a track record in defining portfolio and TA strategies, conducting product and technology valuations and designing partnering and M&A strategies. In addition, Marie-Lyn focuses on medical and commercial go-to-market strategies.
She has published several viewpoints and management articles on topics including strategy, innovation, spin-offs and anti-counterfeiting.
Marie-Lyn holds a PhD in biochemistry from ETH Zurich. Prior to joining strategy consulting, she worked as a postdoc on the development of new cancer drugs at Harvard Medical School in Boston, and novel vaccines at a Max Planck Institute in Berlin.
How Marie-Lyn is building a better working world
Marie-Lyn’s improves patient’s lives through game-changing new therapies and care. To this end, she drives innovation in the pharmaceutical and biotech industries together with her clients. She collaborates with decision-makers and opinion leaders across the globe. Finally, Marie-Lyn creates inclusive and diverse work environments collaborating with clients and teams across the globe.